MAP
Moody Aldrich Partners Portfolio holdings
AUM
$517M
This Quarter Return
+33.86%
1 Year Return
+38.15%
3 Year Return
+181.18%
5 Year Return
+335.56%
10 Year Return
–
AUM
$620M
AUM Growth
+$620M
(+30%)
Cap. Flow
+$27.9M
Cap. Flow
% of AUM
4.51%
Top 10 Holdings %
Top 10 Hldgs %
18.29%
Holding
190
New
37
Increased
54
Reduced
61
Closed
17
Top Buys
| 1 |
Cohen & Steers
CNS
|
$8.46M |
| 2 |
CryoPort
CYRX
|
$7.49M |
| 3 |
Hexcel
HXL
|
$7.3M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
$6.98M |
| 5 |
CCMP
CMC Materials, Inc. Common Stock
CCMP
|
$6.44M |
Top Sells
| 1 |
Chesapeake Utilities
CPK
|
$6.77M |
| 2 |
Unifirst Corp
UNF
|
$6.05M |
| 3 |
Southwest Gas
SWX
|
$5.04M |
| 4 |
ICF International
ICFI
|
$4.83M |
| 5 |
Nomad Foods
NOMD
|
$4.56M |
Sector Composition
| 1 | Financials | 21.75% |
| 2 | Technology | 19.52% |
| 3 | Industrials | 15.23% |
| 4 | Healthcare | 13.39% |
| 5 | Consumer Discretionary | 11.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCRR
76
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $3.82M | 0.62% |
+123,639
| New | +$3.82M |
|
77
Qualys
QLYS
$4.9B
| $3.75M | 0.61% |
30,802
-586
| -2% | -$71.4K |
|
78
Ultragenyx Pharmaceutical
RARE
$3.04B
| $3.56M | 0.57% |
25,732
+60
| +0.2% | +$8.31K |
|
79
Axsome Therapeutics
AXSM
$6.09B
| $3.55M | 0.57% |
43,613
-75
| -0.2% | -$6.11K |
|
|
DCPH
80
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $3.54M | 0.57% |
62,065
+56
| +0.1% | +$3.2K |
|
81
Synaptics
SYNA
$2.62B
| $2.96M | 0.48% |
30,675
+4,447
| +17% | +$429K |
|
82
Installed Building Products
IBP
$7.18B
| $2.95M | 0.48% |
28,947
-18,746
| -39% | -$1.91M |
|
83
Comfort Systems
FIX
$24.7B
| $2.85M | 0.46% |
54,046
+43
| +0.1% | +$2.26K |
|
84
Simpson Manufacturing
SSD
$7.81B
| $2.76M | 0.45% |
+29,550
| New | +$2.76M |
|
85
Array Technologies
ARRY
$1.32B
| $2.67M | 0.43% |
+61,857
| New | +$2.67M |
|
|
VIVO
86
DELISTED
Meridian Bioscience Inc
VIVO
| $2.54M | 0.41% |
135,871
-779
| -0.6% | -$14.6K |
|
87
Novavax
NVAX
$1.2B
| $2.46M | 0.4% |
22,045
-16
| -0.1% | -$1.78K |
|
|
CCXI
88
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.18M | 0.35% |
35,160
+14,661
| +72% | +$908K |
|
|
DRNA
89
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.12M | 0.34% |
96,018
+47
| +0% | +$1.04K |
|
90
Emergent Biosolutions
EBS
$418M
| $2.09M | 0.34% |
23,298
-398
| -2% | -$35.7K |
|
91
FibroGen
FGEN
$48.4M
| $2.06M | 0.33% |
55,564
+41
| +0.1% | +$1.85K |
|
|
KRTX
92
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.97M | 0.32% |
19,407
-11,563
| -37% | -$1.17M |
|
93
Workhorse Group
WKHS
$20M
| $1.97M | 0.32% |
99,323
-49,154
| -33% | -$975K |
|
|
IGMS
94
DELISTED
IGM Biosciences
IGMS
| $1.93M | 0.31% |
21,900
-15,837
| -42% | -$1.4M |
|
95
AllianceBernstein
AB
$4.37B
| $1.9M | 0.31% |
56,217
| – | – |
|
96
Synchrony
SYF
$28.1B
| $1.76M | 0.28% |
50,551
| – | – |
|
97
Esperion Therapeutics
ESPR
$490M
| $1.62M | 0.26% |
62,245
-38,854
| -38% | -$1.01M |
|
98
Nkarta
NKTX
$149M
| $1.61M | 0.26% |
+26,198
| New | +$1.61M |
|
99
Lazard
LAZ
$5.19B
| $1.57M | 0.25% |
37,063
| – | – |
|
100
Zymeworks
ZYME
$1.07B
| $1.55M | 0.25% |
32,824
| – | – |
|